Filing Details
- Accession Number:
- 0001127602-12-021395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-03 14:28:14
- Reporting Period:
- 2012-06-29
- Filing Date:
- 2012-07-03
- Accepted Time:
- 2012-07-03 13:28:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222674 | B John Ziegler | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-06-29 | 736 | $31.72 | 21,390 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-06-29 | 724 | $30.53 | 22,114 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-06-29 | 1,460 | $60.00 | 20,654 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-06-29 | 736 | $0.00 | 736 | $31.72 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-06-29 | 724 | $0.00 | 724 | $30.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2003-07-01 | 2013-07-01 | No | 4 | M | Direct |
0 | 2003-10-01 | 2013-10-01 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2012.